Analysis of senior and high risk benign prostatic hyperplasia by treated transurethral vaporization resection of the prostate

Ming-jun ZHOU,Hai HUANG,Zheng-hui GUO,Ke-wei XU,Chun JIANG,Jian HUANG
DOI: https://doi.org/10.3760/cma.j.issn.1673-4777.2008.07.020
2008-01-01
Abstract:Objective To summarize the clinical therapeutic experience of transurethral vaporization resection of the prostate on senior and high risk benign prostatic hyperplasia. Methods Fifty-six senior and high risk patients with BPH, were treated by transurethral vaporization resection of the prostate (TUVP). Intraoperative techniques and postoperative complications were summarized, and the variables such as international prostate symptom score (IPSS), residual urine volume (RUV), max urine flow rate (Qmax) were recorded and compared pre-and post-operatively. Results Mean operative time was 55 min(40~100min), mean weight of resected tissue was 48.5 g(20~80g), and mean evaluately blood loss was 100 ml (50~150ml). Pro-and post-operatively, IPSS were (27.5±3.0) and (8.9±2.9), RUV were (280±30) ml and (28±10) ml, and Qmax were (8.7±3.8)ml/s and (21.2±6.7) ml/s. All the patients had been followed up for 3~24 months with an average of 12 months. The effect was satisfactory. Two cases were dead due to other elementary diseases, and 1 case was treated by urethral sounding due to urethral stricture. Conclusion Transurethral vaporization resection of the prostate is safe and effective way to deal with the patients with BPH in senior and high risk.
What problem does this paper attempt to address?